全文获取类型
收费全文 | 209篇 |
免费 | 11篇 |
国内免费 | 3篇 |
专业分类
儿科学 | 8篇 |
妇产科学 | 1篇 |
基础医学 | 32篇 |
口腔科学 | 4篇 |
临床医学 | 16篇 |
内科学 | 46篇 |
神经病学 | 20篇 |
特种医学 | 6篇 |
外科学 | 17篇 |
综合类 | 5篇 |
预防医学 | 17篇 |
眼科学 | 6篇 |
药学 | 30篇 |
肿瘤学 | 15篇 |
出版年
2023年 | 6篇 |
2022年 | 8篇 |
2021年 | 15篇 |
2020年 | 11篇 |
2019年 | 11篇 |
2018年 | 16篇 |
2017年 | 13篇 |
2016年 | 12篇 |
2015年 | 7篇 |
2014年 | 13篇 |
2013年 | 18篇 |
2012年 | 25篇 |
2011年 | 28篇 |
2010年 | 9篇 |
2009年 | 3篇 |
2008年 | 8篇 |
2007年 | 10篇 |
2006年 | 5篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2002年 | 2篇 |
排序方式: 共有223条查询结果,搜索用时 15 毫秒
221.
Sara Abbasnezhad Esmaeil Biazar Farzaneh Aavani Mahshad Kamalvand Saeed Heidari Keshel Bahareh Pourjabbar 《International wound journal》2023,20(5):1566-1577
Biological matrices can be modified with cross-linkers to improve some of their characteristics as scaffolds for tissue engineering. In this study, chemical cross-linker 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) was used with different ratios (5, 10, 20, 30, and 40 mM) to improve properties such as mechanical strength, denaturation temperature, and degradability of the acellular fish skin as a biological scaffold for tissue engineering applications. Morphological analysis showed that the use of cross-linker at low concentrations had no effect on the structure and textiles of the scaffold, while increasing mechanical strength, denaturation temperature, and degradation time. Cytotoxicity and cellular studies showed that the optimal cross-linker concentration did not significantly affect cell viability as well as cell adhesion. In general, utilising the carbodiimide cross-linker with the optimal ratio can improve the characteristics and function of the biological tissues such as acellular fish skin. 相似文献
222.
Zahra HosseinpourMostafa Rezaei TaviraniMohammad Esmaeil Akbari 《Asian Pacific journal of cancer prevention》2023,24(5):1571-1582
Background: Breast cancer (BC) is the most common malignancy in women worldwide. Altered miRNA profile can disturb the metabolic homeostatic via regulation of gene expression in BC. Methods: In the present study to evaluate which miRNA, regulate metabolic pathways according to their stage, we performed comprehensive analysis of BC expression (mRNA and miRNA) of a set of patients by comparing samples of solid tumor tissue and adjacent tissue. The mRNA and miRNA data of breast cancer were downloaded from the cancer genome database (TCGA) using TCGAbiolinks package. Differentially expressed (mRNAs and miRNAs) was determined by DESeq2 package and predict valid miRNA-mRNA pairs using multiMiR package. All analyses were performed using the R software. Compound-reaction-enzyme-gene network was constructed using the Metscape a plugin for Cytoscape software. Then, core subnetwork computed by CentiScaPe, another plugin for Cytoscape. Results: In Stage I, hsa-miR-592, hsa-miR-449a and hsa-miR-1269a targeted HS3ST4, ACSL1 and USP9Y genes respectively. In stage II, hsa-miR-3662, Hsa-miR-429, and hsa-miR-1269a targeted GYS2, HAS3, ASPA, TRHDE, USP44, GDA, DGAT2, and USP9Y genes. In stage III, hsa-miR-3662 targeted TRHDE, GYS2, DPYS, HAS3, NMNAT2, ASPA genes. In stage IV, hsa-miR-429, has-miR-23c, and hsa-miR-449a targeted genes GDA, DGAT2, PDK4, ALDH1A2, ENPP2, and KL. Those miRNAs and their targets were identified as the discriminative elements for the four stages of breast cancer. Conclusion: The most notable differences between BC and normal tissue in four stages involved multiple pathways and metabolites include: carbohydrate metabolism (e.g., Amylose, N-acetyl-D-glucosamin, beta-D-Glucuronoside, “”g””-CEHC-glucuronide, “”a””-CEHC-glucuronide, Heparan-glucosamine, 5,6-Dihydrouracil, 5,6-Dihydrothymine), branch-chain amino acid metabolism (e.g., N-Acetyl-L-aspartate, N-Formyl-L-aspartate, N`-acetyl-L-asparagine), Retinal metabolism (e.g., Retinal, 9-`cis`-retinal, 13-`cis`-retinal) and (FAD, NAD) as central coenzymes of metabolism. Set of crucial microRNAs and targeted genes plus the related metabolites were introduced for four stages of BC that can be consider for therapeutic and diagnostic purposes in the different stages of disease. 相似文献
223.
Fateme Gorgani Zahra Esfahani Seyyed-Hadi Ghamari Erfan Ghasemi Sina Azadnajafabad Parnian Shobeiri Esmaeil Mohammadi Sahar Saeedi Moghaddam Mohsen Abbasi-Kangevari Nima Fattahi Yeganeh Sharifnejad Tehrani Yosef Farzi Negar Rezaei Bagher Larijani Farshad Farzadfar 《Journal of gastroenterology and hepatology》2023,38(1):119-128